Zhang, L., Gao, M., & Wang, J. Correspondence on “Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab”by Graser et al. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Liwen, Mingzhu Gao, and Jinyou Wang. Correspondence on “Early Dynamics of Clinical and Laboratory Parameters Predict Primary Refractory Disease in Patients with Metastatic Urothelial Carcinoma Receiving Atezolizumab”by Graser Et Al. BMJ Publishing Group.
MLA (9th ed.) CitationZhang, Liwen, et al. Correspondence on “Early Dynamics of Clinical and Laboratory Parameters Predict Primary Refractory Disease in Patients with Metastatic Urothelial Carcinoma Receiving Atezolizumab”by Graser Et Al. BMJ Publishing Group.